Apertor Pharmaceuticals Inc. was founded in November 2020. Our goal is to bring new immunotherapies to patients by engineering molecular glues using synthetic biology. Our recipe for innovation combines a world-class synthetic biology platform using non-model organisms; a deep knowledge of complex natural products relevant to human health; a computational pipeline enabled by structure-guided design. The result is a first-in-class approach to solving important pharmacological problems and delivering new, high-value treatment options for patients.
We are seeking scientists with expertise in synthetic biology, fermentation and immunology. Apply today to join our growing team of talented scientists!
To learn more about us, visit us on the web at: https://apertorpharma.com/